Melius MicroBiomics Inc.
The Gibson Lab created two genetically engineered microbial medicines (GEMM™), BioPersist™ & BioColonize™. Melius MicroBiomics Inc. has licensed this UBC IP to take these products to market. Dr. Deanna Gibson is the current Chief Scientific Officer (CSO) of Melius.
Learn more here
